EHDEN Research Coordinator receives ISPE Special Award for Epidemiology and Public Health

Brussels, Belgium, 5th September 2022: We are delighted to announce and celebrate the special award from the International Society of Pharmacoepidemiology (ISPE) for recognisable and impactful contributions to public health during the COVID-19 pandemic awarded to Prof Dani Prieto-Alhambra, EHDEN’s Research Coordinator, Professor of Pharmaco and Device Epidemiology, NDORMS, University of Oxford, and Professor, Real World Evidence, Erasmus MC.

Dani was also previously elected to the ISPE Board of Directors in June 2021 (link), and elected as a member of the European Network of Centres for Pharmaoepidemiology and Pharmacovigilance (ENCePP) Steering Group in December 2020 (link).

ISPE is an international organisation dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy, education, and advocacy in the field of pharmacoepidemiology, including such areas as pharmacovigilance, drug utilisation research, comparative effectiveness review, and therapeutic risk management.

Prof Prieto-Alhambra commented, “This is an award that recognises the work of many of my colleagues at Oxford, Erasmus MC, throughout Europe in the EHDEN network, and globally through the OHDSI community. Senior awards like this take a village, and this one in particular took a large town of researchers and collaborators.”

EHDEN is delighted to see this recognition of Dani in his capacity at Oxford and Erasmus MC, and as Research Coordinator for EHDEN. This originated from his drive to recover from the cancellation of the OHDSI Europe Symposium in 2020 at Oxford due to the COVID-19 pandemic, and initiating the OHDSI COVID-19 study-a-thon in March 2020 to address unmet evidence needs as the pandemic evolved globally (news link), and to date with ongoing research.

This is also recognition of the open science and federated approach to evidence generation utilising the OMOP common data model, rapid analysis network studies and evidence generation to impact today and not in several tomorrows at the core of EHDEN and OHDSI.